story of the week
Trofinetide Shows Potential for Treating Fragile X Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Pediatric Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome
Pediatr. Neurol. 2020 Sep 01;110(xx)30-41, E Berry-Kravis, JP Horrigan, N Tartaglia, R Hagerman, A Kolevzon, CA Erickson, S Hatti, M Snape, A Yaroshinsky, G Stoms, FXS-001 Investigators, L Glass, NE JonesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.